• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

60岁以下患者行心包生物瓣主动脉瓣置换术。10年经验

[Aortic valve replacement with pericardial bioprosthesis in patients under 60 years of age. Experience over 10 years].

作者信息

Aupart M, Hammami S, Sirinelli A, Dreyfus X, Meurisse Y, Marchand M

机构信息

Unité de Chirurgie Cardiaque, Hôpital Trousseau, TøURS.

出版信息

Ann Chir. 1996;50(5):367-73.

PMID:8761106
Abstract

Between July 1984 and December 1993. 110 patients, younger than 60 years, underwent aortic valve replacement with a Carpentier-Edwards pericardial valve. 75.5% were male, with a mean age of 49.6 years (range: 16 to 59 years). Mean clinical status was 2.25. Operative mortality was 0%. All patients but 3 were followed up with a total follow-up of 454 patient-years and an average of 4.8 years. The 10-year actuarial survival is 91 +/- 6%. We observed 8 valve-related complications (1.7% patient-years): 3 cases of endocarditis, 3 structural failures, 1 thromboembolic event, and 1 perivalvular leak. 1 patient died from a valve-related cause, and 2 reoperations were necessary. The 8-year actuarial probability of absence of valve-related death is 99 +/- 1%, thromboembolism 98 +/- 2%, endocarditis 96 +/- 4%; reoperations 96 +/- 4%, and valve failure 97 +/- 3%. The 10-year valve-related complication rate is satisfactory, but the durability of the prosthesis in this group of young patients remains unknown. A longer follow-up is mandatory to draw definitive conclusions.

摘要

1984年7月至1993年12月期间,110名年龄小于60岁的患者接受了Carpentier-Edwards心包瓣膜主动脉瓣置换术。75.5%为男性,平均年龄49.6岁(范围:16至59岁)。平均临床状况评分为2.25。手术死亡率为0%。除3例患者外,所有患者均接受了随访,总随访时间为454患者年,平均随访4.8年。10年精算生存率为91±6%。我们观察到8例瓣膜相关并发症(1.7%患者年):3例心内膜炎、3例结构故障、1例血栓栓塞事件和1例瓣周漏。1例患者死于瓣膜相关原因,2例需要再次手术。无瓣膜相关死亡的8年精算概率为99±1%,血栓栓塞为98±2%,心内膜炎为96±4%;再次手术为96±4%,瓣膜故障为97±3%。10年瓣膜相关并发症发生率令人满意,但该组年轻患者人工瓣膜的耐久性仍不清楚。必须进行更长时间的随访才能得出明确结论。

相似文献

1
[Aortic valve replacement with pericardial bioprosthesis in patients under 60 years of age. Experience over 10 years].60岁以下患者行心包生物瓣主动脉瓣置换术。10年经验
Ann Chir. 1996;50(5):367-73.
2
Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.Carpentier-Edwards 心包生物瓣主动脉瓣置换术的远期结果:1000 例患者长达 17 年的随访。
Ann Thorac Surg. 2010 May;89(5):1410-6. doi: 10.1016/j.athoracsur.2010.01.046.
3
Twelve-year experience with the 19 mm Carpentier-Edwards pericardial aortic valve.使用19毫米卡朋蒂埃-爱德华兹心包主动脉瓣膜的十二年经验。
J Heart Valve Dis. 1998 Sep;7(5):534-9.
4
The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients.主动脉位置上的最后一代心包瓣膜:589例患者的十年随访
Ann Thorac Surg. 1996 Feb;61(2):615-20. doi: 10.1016/0003-4975(95)00953-1.
5
Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients.用于主动脉钙化狭窄的百慕大心包生物瓣膜:1133例患者的18年经验
J Heart Valve Dis. 2006 Nov;15(6):768-75; discussion 775-6.
6
Double valve replacement with the Carpentier-Edwards pericardial valve: 10-year results.
J Heart Valve Dis. 1996 May;5(3):312-6.
7
Early mechanical failures of the Hancock pericardial xenograft.汉考克心包异种移植的早期机械故障。
J Thorac Cardiovasc Surg. 1987 Aug;94(2):200-7.
8
[Influence of the valve position on the complications related to pericardial Carpentier-Edwards valve after 8 years].[8年后瓣膜位置对心包内Carpentier-Edwards瓣膜相关并发症的影响]
Arch Mal Coeur Vaiss. 1995 Jul;88(7):967-71.
9
Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.采用卡彭蒂埃-爱德华兹心包生物瓣膜进行主动脉瓣和二尖瓣置换术:10年随访结果
J Heart Valve Dis. 1996 Jan;5(1):45-9.
10
Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.低剂量阿司匹林用于Tissuemed猪主动脉生物假体血栓预防的经验:五年经验调查
J Heart Valve Dis. 1998 Sep;7(5):574-9.